| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $11.0M | -0.1% |
| Cost of Revenue | $3.2M | +14.7% |
| R&D Expense | $4.9M | -18.1% |
| SG&A Expense | $4.1M | -5.5% |
| Operating Income | -$2.1M | +43.4% |
| Pre-tax Income | -$1.1M | +69.7% |
| Income Tax | -$20K | +88.2% |
| Net Income | -$1.1M | +68.7% |
| EPS (Basic) | -$0.12 |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $13.6M | -8.0% |
| Accounts Receivable | $93K | -24.2% |
| Current Assets | $14.8M | -4.2% |
| Total Assets | $23.9M | -6.1% |
| Current Liabilities | $3.1M | -14.3% |
| Total Liabilities | $3.8M | -15.8% |
| Stockholders' Equity | $20.1M | -4.0% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$1.1M | +63.5% |
| Investing Cash Flow | -$85K | +97.1% |
| Financing Cash Flow | -$7K | +99.3% |
| +65.7% |
| EPS (Diluted) | -$0.12 | +65.7% |